Fox Run Management, L.L.C. Recursion Pharmaceuticals, Inc. Transaction History

Fox Run Management, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$7.35 - $10.05 $12,921 - $17,667	-1,758 Reduced 12.5%	12,311 $92,000
Q1 2024 May 13, 2024	BUY	$9.13 - $15.52 $128,449 - $218,350	14,069 New	14,069 $140,000
Q2 2023 Aug 11, 2023	BUY	$4.56 - $9.94 $9,954 - $21,699	2,183 Added 13.05%	18,917 $141,000
Q1 2023 May 12, 2023	BUY	$6.42 - $9.64 $107,432 - $161,315	16,734 New	16,734 $111,000

286

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.35B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.